US 12240908
N-terminal scFv multispecific binding molecules
granted A61KA61K2039/505A61P
Quick answer
US patent 12240908 (N-terminal scFv multispecific binding molecules) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61P, A61P3/00, A61P3/06